1. Background {#sec124037}
=============

**Staphylococcus aureus** is a commensal and a major opportunistic pathogen that causes a wide variety of diseases in humans and animals, with a high impact on public health and the livestock industry ([@A22413R1], [@A22413R2]). This organism is recognized worldwide as a major pathogen causing mastitis in lactating cows, sheep and goats ([@A22413R3]). Although the udder is considered to be the main source of infection, other areas such as the nares are probable sources of contamination for udder and milk in dairy farms ([@A22413R4]). Recently, isolation of *S. aureus* from the nares of farm animals has been frequently reported ([@A22413R5]-[@A22413R7]).

Antimicrobial resistance profile of *S. aureus* is also of great concern. β-lactams, macrolides and tetracyclines are commonly used antibiotics for the treatment of staphylococcal infections and the level of resistance to these antibiotics is growing quickly among staphylococci ([@A22413R8]). Resistance genes for penicillin (*blaZ*, which encodes β-lactamase), methicillin (*mecA*, which encodes a low-affinity penicillin-binding protein \[PBP2a\]), erythromycin (*ermA* and *ermB*, which encode ribosomal methylases), and tetracycline (*tetK*and *tetM*, which encode a tetracycline efflux pump and a ribosomal protection protein, respectively) have been frequently reported among isolates of *S. aureus* ([@A22413R9]-[@A22413R11]).

Several studies have provided evidence of transmission of antibiotic-resistant *S. aureus* (of particular concern Methicillin-Resistant *Staphylococcus aureus* (MRSA)) among animals, farm environments, and farmers ([@A22413R12]-[@A22413R14]). Additionally, transfer of antibiotic-resistant *Staphylococcus aureus* to humans (or their resistance genes) via the food chain ([@A22413R15]), poultry ([@A22413R16]), meat and dairy products ([@A22413R17], [@A22413R18]), has already been reported. This may represent a zoonotic risk factor for human colonization or difficult-to-treat infections. Therefore, more attention needs to be paid to detection of antibiotic-resistant *S. aureus* in order to achieve an effective treatment for *S. aureus* infections. In human medicine, *S. aureus* nasal carriage has been extensively studied in patients and healthy individuals ([@A22413R19], [@A22413R20]). In Iran, resistance and nasal carriage of *S. aureus* in healthy children ([@A22413R21]) and health care workers ([@A22413R22]) have also been studied. The latter research also concluded that *S. aureus* could be transmitted from health care workers to hospitalized patients. However, neither the *S. aureus* nasal carriage rate nor its antimicrobial susceptibly patterns are known in ruminants.

2. Objectives {#sec124038}
=============

The aims of the present study were to determine the frequency of nasal carriage of *S. aureus* among healthy ruminants and to investigate the genes involved in resistance to penicillin (*blaZ*), methicillin (*mecA*), tetracycline (*tetK*and *tetM*) and erythromycin (*ermA* and *ermC*) by the Polymerase Chain Reaction (PCR).

3. Materials and Methods {#sec124044}
========================

3.1. Sample Collection {#sec124039}
----------------------

During the period between January 2011 and May 2012, a total of 201 nasal swab samples were taken from healthy ruminants including 79 cattle, 78 sheep and 44 goats housed in three different areas (Khorramabad, Noor Abad, and Urmia) of Iran. For all animals, cotton swabs were inserted into the anterior nares of both left and right nostrils and were softly rolled against the inner walls. The Urmia University of Veterinary Ethical Committee approved the animal protocol for this study (K2-427). One swab was used to take a sample from both nostrils and then stored in Tryptone Soy Broth (TSB) (Merck, Germany) at 4°C prior to laboratory analysis. Cultures were incubated at 37°C for 24 hours and then streaked directly on plates of Mannitol Salt Agar (MSA) (Merck, Germany) and incubated at 37°C for 18 to 48 hours ([@A22413R23]). The suspected *S. aureus* colonies were purified on sheep blood agar plates and then identified by standard biochemical tests including Gram staining, catalase reaction, oxidase reaction, mannitol fermentation and coagulase production ([@A22413R24]). **Staphylococcus aureus** isolates were stored in TSB containing 15% glycerol at -20°C until needed.

3.2. DNA Extraction {#sec124040}
-------------------

For DNA extraction, *S. aureus* isolates were grown over night at 37°C in Brain Heart Infusion broth (BHI, Merck, Germany). Cells were pelleted and suspended in 200 μL of sterile Tris-Ethylenediaminetetraacetic acid (TE) buffer (pH 8.0). Next, DNA was extracted using the Genomic DNA purification Kit (Thermo Scientific, Germany) with some modifications. The extracted DNA was then stored at -20°C.

3.3. Genotypic Determination of *Staphylococcus aureus* {#sec124041}
-------------------------------------------------------

Identification of the *S. aureus* species was confirmed by PCR amplification of the *nuc* gene using primers and protocol described by Brakstad et al. ([@A22413R25]).

3.4. Polymerase Chain Reaction Amplification of the Antibiotic Resistance Genes {#sec124042}
-------------------------------------------------------------------------------

Polymerase Chain Reaction amplification of antibiotic resistance genes was carried out in a CORBETT thermocycler (Model CP2-003, Australia) using PCR master kit (SinaClon, Iran) with 25 μL mixtures including 12.5 μL of 2X master mix, 1 μM of each primer and 4 μL of extracted DNA. Sterile water was added instead of nucleic acids for the negative control. The *mecA*PCR program included denaturation at 94°C for five minutes followed by 40 cycles at 94°C for 30 seconds, 55°C for 30 seconds, 72°C for one minutes. A final extension at 72°C for five minutes completed the amplification ([@A22413R26]). The *blaZ* amplification was performed under the following conditions: initial denaturation at 94°C for five minutes followed by 35 cycles at 94°C for 30 seconds, 55°C for 30 seconds, 72°C for 30 seconds with a final extension of 72°C for 10 minutes ([@A22413R27]). The PCR conditions for *tet* (K and M) and also *erm* (A and C) genes were as follows: initial denaturation at 94°C for three minutes followed by 30 cycles at 94°C for 30 seconds, 55°C for 30 seconds, 72°C for 30 seconds with a final extension at 72°C for four minutes ([@A22413R28]). The PCR primers used to detect the studied antibiotic resistance genes were synthesized by the SinaClon Company of Tehran, Iran ([Table 1](#tbl31981){ref-type="table"}).

###### Oligonucleotide Sequences of the Primers Used in This Study

  Target Gene   Sequence 5\' - 3\'       PCR Product   Reference
  ------------- ------------------------ ------------- ----------------
  ***mecA***                                           
  F             AAAATCGATGGTAAAGGTTGGC   532 bp        ([@A22413R26])
  R             AGTTCTGCAGTACCGGATTTGC                 
  ***blaZ***                                           
  F             AAGAGATTTGCCTATGCTTC     518 bp        ([@A22413R27])
  R             GCTTGACCACTTTTATCAGC                   
  ***tetK***                                           
  F             GTAGCGACAATAGGTAATAGT    360 bp        ([@A22413R28])
  R             GTAGTGACAATAAACCTCCTA                  
  ***tetM***                                           
  F             AGTGGAGCGATTACAGAA       158 bp        ([@A22413R28])
  R             CATATGTCCTGGCGTGTCTA                   
  ***ermA***                                           
  F             AAGCGGTAAACCCCTCTGA      190 bp        ([@A22413R28])
  R             TTCGCAAATCCCTTCTCAAC                   
  ***ermC***                                           
  F             AATCGTCAATTCCTGCATGT     299 bp        ([@A22413R28])
  R             TAATCGTGGAATACGGGTTTG                  

3.5. Agarose Gel Electrophoresis {#sec124043}
--------------------------------

The PCR products were separated on 1.2% (w/v) agarose gel (Sigma-Aldrich, Germany) containing 0.5 µg/mL ethidium bromide (Sigma-Aldrich, Germany). Electrophoresis was performed in 0.5x Tris/Borate/EDTA (TBE) buffer at 100 V for one hour. The resulting PCR products were visualized under UV light using a transilluminator (BTS-20M, Japan) and the 100 bp DNA ladder plus was used as the molecular size marker.

4. Results {#sec124045}
==========

Among the 201 nasal samples of ruminants tested in this study, 26 were positive for *S. aureus* recovery. The amount of *S. aureus*-positive nasal swabs corresponding to cattle, sheep and goats were four (5.06%), 11 (14.1%) and 11 (25%) isolates, respectively.

Using the PCR assay, detection of determinants of resistance to methicillin (*mecA*), penicillin (*blaZ*), tetracyclines (*tetK*and *tetM*), and MLSB (*ermA* and *ermC*) was done through successful amplification of a unique DNA fragment of the expected sizes ([Figures 1](#fig23607){ref-type="fig"}, [2](#fig23608){ref-type="fig"} and [3](#fig23609){ref-type="fig"}).

![Agarose Gel Electrophoresis of Polymerase Chain Reaction Product of *mecA*Gene\
Lane M: 100 bp DNA marker (Fermentas, Germany); Lane 1: positive control of amplified 532-bp DNA (*S. aureus* ATCC 33591); Lane 2: negative control (reaction mixture without DNA); Lanes 3 - 6: representative *S. aureus* nasal isolates negative for *mecA*; Lane 7: the only *S. aureus* isolate positive for the *mecA*gene.](jjm-08-10-22413-g001){#fig23607}

![Agarose Gel Electrophoresis of Polymerase Chain Reaction Product of *Blaz* Gene\
Lane M: Gene ruler, 100 bp DNA ladder plus marker (Fermentas, Germany); Lane 1: positive control of amplified 518-bp DNA (*S. aureus* ATCC 29213); Lane 2: negative control (reaction mixture without DNA); Lanes 3 - 9: representative *S. aureus* nasal isolates positive for the *blaZ* gene.](jjm-08-10-22413-g002){#fig23608}

![Agarose Gel Electrophoresis of Polymerase Chain Reaction Products of *tet* (K and M) and *erm* (A and C) Genes\
Lanes M: 100 bp DNA marker (Fermentas, Germany); Lane 1: positive control for *tetK*gene of amplified 360-bp DNA (*S. aureus* ATCC BAA-39); Lane 2: negative control (reaction mixture without DNA); Lanes 3 - 5: *S. aureus* isolates positive for *tetK*gene; Lane 6: positive control for *tetM* gene of amplified 158-bp DNA fragment (*S. aureus* T0131); Lane 7: negative control (reaction mixture without DNA); Lanes 8 - 10: representative *S. aureus* nasal isolates negative for *tetM*; Lane 11: the only *S. aureus* isolate positive for *tetM* gene; Lane 12: positive control for *ermA* gene of amplified 190-bp DNA (*S. aureus* T0131); Lane 13: negative control for *ermA* gene; Lanes 14 - 16: representative *S. aureus* nasal isolates negative for *ermA* gene; Lane 17: positive control for *ermC*gene of amplified 299-bp DNA (*S. aureus* 71193); Lane 18: negative control for *ermC*gene; Lanes 19 - 21: representative *S. aureus* nasal isolates negative for *ermC*gene.](jjm-08-10-22413-g003){#fig23609}

###### The Frequencies of Resistance Genes Amongst Twenty-Six *S. aureus* Nasal Isolates From Ruminants

  Animal Origin   Number of Isolates   Antibiotic Resistance Gene                  
  --------------- -------------------- ---------------------------- ----- -------- ----
  **Cattle**                                                                       
                  2                    \+                           \-    \-       \-
                  2                    \+                           \-    *tetK*   \-
                  \-                   \-                           \-    *-*      \-
  **Sheep**                                                                        
                  8                    \+                           \-    *-*      \-
                  1                    \+                           \+    *tetK*   \-
  2               \-                   \-                           *-*   \-       
  **Goat**                                                                         
                  6                    \+                           \-    *-*      \-
                  1                    \+                           \-    *tetM*   \-
                  4                    \-                           \-    *-*      \-

5. Discussion {#sec124046}
=============

The colonized *S. aureus* in the ruminant's nasal cavities may be considered as a probable source of staphylococcal infections ([@A22413R4], [@A22413R6], [@A22413R29]). In this study, a total of 26 *S. aureus* isolates were identified from 201 nasal swabs (12.9%) of ruminants including cattle, sheep and goats, by culture as well as species specific PCR. The frequency detected in the present study was, however, lower than the 43.7% reported for the same species in Saudi Arabia ([@A22413R23]).

The present study indicated a relatively low prevalence of *S. aureus* nasal carriage (5.06%) in healthy cattle. This finding agrees with earlier reports from Norway and Sweden that evaluated potential sources of *S. aureus* in dairy herds ([@A22413R6], [@A22413R30]). However, this study showed a higher percentage of *S. aureus* nasal carriage in healthy sheep and goats. Such results are also similar to those previously reported for Norwegian dairy goats ([@A22413R6], [@A22413R29]) and dairy sheep ([@A22413R4], [@A22413R6]). Although the percentage of *S. aureus* nasal carriage in cattle was remarkably lower than those observed in sheep and goats, yet the reason for this is not clear. This variation could at least partly be due to differences in nasal physiology and self-care behaviors such as nose licking in cattle.

The high prevalence of *S. aureus* in the nasal cavity of small ruminants may be a predisposing factor for subsequent Intra-Mammary Infection (IMI), which needs additional comparative studies. In this regard, the nasal cavity of small ruminants has been proposed as the primary reservoir of *S. aureus* by some researchers ([@A22413R4], [@A22413R6], [@A22413R29]).

Emergence of drug resistance organisms, especially MRSA, is a particular concern to both animal health and public health. There is now increasing evidence that MRSA can colonize and cause infection in companion animals as well as animals of the food chain ([@A22413R31]). Furthermore, a few studies have reported a lower prevalence of MRSA in bovine and ovine mastitis ([@A22413R32], [@A22413R33]). Therefore, efforts should be made to characterize possible reservoirs in order to reduce the spread of MRSA. It has been shown that MRSA can colonize nares of ruminants ([@A22413R23]). Similar to the results of other studies ([@A22413R34], [@A22413R35]), MRSA was not isolated from any of the cattle nasal swabs. However, this finding was inconsistent with the findings of Spohr et al. ([@A22413R36]). In contrast to a previous study ([@A22413R37]), none of the nasal isolates from goats carried the *mecA*gene. In the present study, only one out of 26 (3.84%) isolates harbored the *mecA*gene, which originated from sheep. This result is consistent with the findings of Gharsa et al. ([@A22413R7]) where five of 163 healthy sheep (3%) carried MRSA in their nares. As, zoonotic transfer of MRSA has been reviewed between different animals and humans ([@A22413R38]), more research should be done in this field in different parts of Iran to apply necessary management and health measures to prevent the spread of MRSA strains.

In the current study, a total of 20 out of 26 *S. aureus* nasal isolates possessed the *blaZ* gene. In similar studies conducted in Tunisia to assess *S. aureus* nasal carriage in sheep ([@A22413R7]), cattle and goats (41), lower rates of *blaZ*-carrying *S. aureus* were identified. Differences in antibiotic regimens used in treating infections may explain these discrepancies among countries. Extensive use of β-lactam group of antibiotics for the treatment of animals in Iran ([@A22413R39]) might explain the development of penicillin resistance among microbial strains isolated from farms animals in several reports from Iran ([@A22413R40], [@A22413R41]). These results indicate the need for effective transmission control of penicillin resistance in ruminants.

In Iran, tetracycline class of antibiotics remain as the first-line treatment of infections in livestock ([@A22413R42]). Of the 26 isolates tested, four (15.4%) were positive for the presence of *tet* (*K* and *M*) genes, of which two isolates were obtained from cattle, while the other two isolates were from sheep and goats. Our results are in contrast with the results of Gharsa et al. ([@A22413R43]), where no *tetK*and *tetM* genes were detected in cattle and goats nasal *S. aureus* isolates, yet similar to those reported for sheep isolates ([@A22413R7]). It should be noted that the *tet*+ isolates harbored *tetK*more frequently than *tetM*, indicating that the tetracycline resistance mechanism is commonly mediated by the tetracycline efflux pump. This can be explained by their typical genetic locations, for example the *tetK*gene on small multicopy plasmids and *tetM* on conjugative transposon Tn916, which contribute to the spread of these determinants ([@A22413R44]).

In this study, the *ermA* and *ermC*genes were not detected in any of the *S. aureus* isolates. This finding is consistent with previous studies on *S. aureus* isolates from nasal cavity of cattle and goats ([@A22413R34]). However, in a study carried out by Gharsa et al. ([@A22413R7]), 5.47% of the *S. aureus* isolates from nasal cavity of healthy sheep were positive for the *ermC*gene ([@A22413R7]).

In general, the resistance gene patterns observed for *S. aureus* isolates from the nasal cavity of ruminants seems to reflect the patterns of drug therapy in these animal species. This was confirmed by veterinarians in the studied regions where the treatment plan of ruminant clinical infections is mainly based on using roughly 50% penicillin, 30% tetracycline, 20% other antibiotics including tylosin and gentamicin, and seldom use of macrolide antibiotics.

The presence of resistance genes among nasal isolates of *S. aureus* from ruminants in this study indicates that these species can serve as a cause of infection for humans. Transmission of *S. aureus* and its methicillin resistant variant between animals and humans has been frequently reported via direct contact ([@A22413R45]) or indirect routes such as the environment and food chain ([@A22413R14], [@A22413R46]).

In conclusion, our findings show that the nares of healthy ruminants may represent a reservoir for antibiotic resistant *S. aureus*, underscoring the need for further extensive research to devise contextual control and prevention strategies. To our knowledge, this is the first survey in Iran examining the prevalence and resistance characteristics of *S. aureus* nasal isolates from ruminants.
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